Middle and Inner Ear Malformation in Children With Velocardiofacial Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-01-31

Study Completion Date

2007-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Middle and inner ear malformations on two boys with velocardiofacial syndrome are discussed.Special attention should be given to the presence of hearing loss due to middle and inner ear malformations, in addition to frequent conductive hearing loss regarding mastoid and middle ear inflammatory processes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Two boys with clinical signs of velocardiofacial syndrome, at ages of 4.7 and 6,7 years old are the subjects of this study.Audiological evaluation, including pure tone audiometry, tympanometry, acoustical reflex, and Computerized Tomography of temporal bones, and analyses of DNA sample with markers of 22q11 region were performed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ear Malformations in the Velocardiofacial Syndrome

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Syndrome Velocardiofacial Middle ear Inner ear Malformation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects with velocardiofacial syndrome

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pontificia Universidade Catolica de São Paulo

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alfredo Tabith-Junior, MD

Role: PRINCIPAL_INVESTIGATOR

Pontificia Universidade Católica de São Paulo

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Unique protocol

Identifier Type: -

Identifier Source: org_study_id